• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid-sparing effects of IV acetaminophen for patients undergoing surgery
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol therapy with inhalers during mechanical ventilation
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-articular hyaluronic acid for osteoarthritis of the hip, shoulder, and ankle
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Timing of antibiotic therapy for neisseria gonorrhoeae infection
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical and instrumental swallowing assessments for dysphagia
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Ketorolac for renal colic
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Ketamine for adults with substance use disorders
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Ketamine for adults with treatment-resistant depression or posttraumatic stress disorder: a 2023 update
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: urethral discharge - diagnostic measures and pharmacological treatment]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: a brief overview of indicators for care and service transitions of community-dwelling seniors with major neurocognitive disorder (MNCD) in Quebec]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: an overview of emergency department visits and hospitalizations among young people aged 6 to 25 for mental health and psychosocial issues in 2022–2023, compared to the pre-pandemic (2016–2020) and pandemic periods (2020–2022) of COVID-19]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: expressing wishes regarding goals of care and the decision about cardiopulmonary resuscitation]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: plasma sC5b-9 assay]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding newborn screening for congenital adrenal hyperplasia to the Quebec newborn blood screening program]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: healthcare systems in the future: what priorities guide innovation?]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: methodological report in support of the reflection guide supporting clinical and organizational practices in rehabilitation services for young people with adjustment problems aged 10 or older]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: type 2 diabetes screening and cardiovascular risk assessment]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: dosing of a new generation anti-seizure panel by LC-MS/MS]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: overview of chronic obstructive pulmonary disease in Quebec from 2016 to 2022 - healthcare Indicator results]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Rapid response: mitigation strategies to counter the shortage of sublingual nitroglycerin sprays and tablets]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: the experience of people living with neurocognitive disorders in Quebec]
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Buprenorphine formulations for opioid use disorder
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic drugs for severe asthma
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Aging in place
2024     Ontario Health Interferon-gamma release assay testing for latent tuberculosis infection: a health technology assessment
2024     Ontario Health Single-exposure, dual-energy subtraction flat panel x-ray detectors: a health technology assessment
2024     Ontario Health Peripheral nerve stimulation for chronic neuropathic pain: a health technology assessment
2024     Ontario Health Plasma-based comprehensive genomic profiling DNA assays for non–small cell lung cancer: a health technology assessment
2024     Ontario Health Pelvic floor muscle training for stress urinary incontinence, fecal incontinence, and pelvic organ prolapse: a health technology assessment
2024     Ontario Health Fractional exhaled nitric oxide testing for the diagnosis and management of asthma: a health technology assessment
2024     Ontario Health Sucrose octosulfate (SOS)-impregnated dressings for adults with difficult-to-heal noninfected diabetic foot ulcers and difficult-to-heal noninfected venous leg ulcers
2024     Ontario Health Level 2 polysomnography for the diagnosis of sleep disorders: a health technology assessment
2024     Ontario Health Intrathecal drug delivery systems for cancer pain
2024     Ontario Health Minimally invasive bleb surgery for glaucoma: a health technology assessment
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pharmacotherapy for transplant ineligible multiple myeloma
2023     Institute of Health Economics (IHE) The impact of extreme heat events on health and health systems in Alberta: adaptation and mitigation strategies
2023     Institute of Health Economics (IHE) Optimizing MRI service capacity: review of the relationship between MRI delay and outcomes
2023     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Support for the implementation of new ways of working at the Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale]
2023     WorkSafeBC Cryoneurolysis for shoulder pain
2023     Ontario Health Carrier screening programs for cystic fibrosis, fragile X syndrome, hemoglobinopathies and thalassemia, and spinal muscular atrophy
2023     Ontario Health Robotic-assisted hysterectomy for endometrial cancer in people with obesity
2023     Ontario Health Robotic-assisted partial nephrectomy for kidney cancer
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: innovations in home support, at the crossroads of humanity and technology]
2023     WorkSafeBC Creatine supplementation for treating concussions
2023     WorkSafeBC Glutamine for treating concussions
2023     WorkSafeBC Koebner phenomenon in connective tissue
2023     WorkSafeBC The effect of pepper spray on human health
2023     WorkSafeBC Myalgic encephalomyelitis/chronic fatigue syndrome associated with mRNA COVID-19 vaccination
2023     WorkSafeBC Platelet rich plasma as treatment for medial epicondylitis
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of Intercept and Mirasol - pathogen reduction technologies for the treatment of labile blood products in Quebec]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: principles and criteria guiding the use of parent-child trio genomewide sequencing in constitutional genetics - a report to support the work of the RQDM]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: urinary tract infection in people aged 14 and over - diagnostic guidelines, optimal use of 1st- and 2nd-line treatments and follow-up ]
2023     WorkSafeBC Low intensity pulsed ultrasound (LIPUS) for preventing fractures
2023     WorkSafeBC Efficacy of eye movement desensitization and reprocessing (EMDR) as treatment for major depression
2023     WorkSafeBC Firefighting and polycythemia vera
2023     WorkSafeBC HEPA filters and nanomaterials
2023     WorkSafeBC Hemorrhoids and heavy lifting
2023     WorkSafeBC Association between wearing orthosis and developing metatarsal stress fractures
2023     WorkSafeBC Causal association between firefighting and hypersensitivity pneumonitis
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [At a glance: screening and management algorithm management of precancerous lesions - cervical cancer and population-based screening]
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic drugs for severe asthma
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental polishing for oral health
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraocular lenses for cataract surgery
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Refractive laser surgery for vision conditions
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Buprenorphine naloxone film versus tablets for opioid use disorder
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Case carts in surgical settings
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Anti–vascular endothelial growth factor drugs for age-related macular degeneration
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care ultrasound for guided central venous catheter insertion
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) IV acetaminophen for acute pain in emergency departments
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Semaglutide 2 mg for type 2 diabetes
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Midline and extended dwell catheters for IV antibiotics
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Radiofrequency ablation for chronic knee, hip, and shoulder pain
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct-acting antivirals for pediatric chronic hepatitis C virus infection
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin for short stature
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-sterile glove use
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Early intervention programs for adolescents and young adults with eating disorders
2023     Ontario Health Bariatric surgery for adults with class I obesity and difficult-to-manage type 2 diabetes
2023     Ontario Health Robotic-assisted hysterectomy for endometrial cancer in people with obesity: a health technology assessment
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Emergency department overcrowding in Canada: an update
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: gene panel for the identification of myeloid mutations by NGS ‒ evaluation report on the repatriation of an analysis carried out outside of the province of Québec]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: resuscitation in community opioid overdose ‒ update and complement to INESSS guidance published in 2018 - Cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: organizational models for the management of spinal cord injuries]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: benchmarks to improve services for at-risk or neglected children and their families]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Rapid response: Cervical cancer: transition from from Pap test screening to HPV testing]
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of adult patients with chronic immune thrombocytopenia after failure of first-line therapies
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Dental bridges for partial tooth loss
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Optune - for the treatment of adult patients with newly diagnosed glioblastoma]
2023     WorkSafeBC Cold plunges as treatment for concussions
2023     WorkSafeBC Flotation therapy as treatment for concussions
2023     WorkSafeBC Efficacy of under-mask beard covers in quantitative fit testing of tight-fitting disposable respirators
2023     WorkSafeBC Causal association between COVID-19 infection and irritable larynx syndrome
2023     WorkSafeBC Migraines and the (Moderna) COVID-19 vaccine
2023     WorkSafeBC Botulinum toxin as treatment for neck strains
2023     WorkSafeBC Esketamine as treatment for depression and PTSD
2023     WorkSafeBC Platelet rich plasma in treating (recurrent) anterior shoulder dislocation
2023     WorkSafeBC Causal association between carpal tunnel release surgery and trigger finger
2023     WorkSafeBC Causal association between SARS-Cov-2 infection and the development of trigeminal neuralgia
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: models for coordinating interhospital transfers in critical care]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: asthma management in children and adults]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: implantable medical device tracking methods]